Preliminary Study on the Possibility to Detect Virus Nucleic Acids in Post-Mortem Blood Samples.


Journal

Frontiers in bioscience (Landmark edition)
ISSN: 2768-6698
Titre abrégé: Front Biosci (Landmark Ed)
Pays: Singapore
ID NLM: 101612996

Informations de publication

Date de publication:
07 06 2022
Historique:
received: 23 12 2021
revised: 09 05 2022
accepted: 20 05 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: ppublish

Résumé

In many forensic cases, the medical records of the deceased are not available at the time of the autopsy; therefore, no information about the deceased's state of health, including any infectious diseases contracted during life, is accessible. The detection of some of the principal viral infections, such as hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus type 1 (HIV-1), could contribute to determining causes of death and interesting applications could be found in medico-legal practice, such as occupational risk assessment. To date, accurate and sensitive serological and molecular assays capable of detecting these viruses have been validated on biological samples taken from living beings, while their efficiency on forensic post-mortem biological samples has yet to be thoroughly assessed. To further this aim, this study evaluated whether the nucleic acid amplification techniques (NAATs) for the detection of viral genomes that are applied in clinical settings can be used, with the same success rate, for these latter samples. Manual viral nucleic acid extraction processes and fully-automated amplification-based detection techniques developed in-house were evaluated on blood samples taken during the routine autopsies of 21 cadavers performed 2 to 9 days after death. Information on HBV, HCV, and HIV-1 seropositive status was previously known for only four of these cadavers. Using automated quantitative real-time PCR (qPCR) and qualitative PCR (end-point) analyses, it was possible to confirm the presence of viral genomes in the four post-mortem whole blood samples with previously reported specific serological positivity. In addition, the genomes of HCV and/or HIV-1 genomes were detected in three other blood samples with unknown serological status at the time of autopsy. Therefore, our findings suggest that molecular assays may detect the presence of viral genomes in forensic post-mortem blood samples up to five days after death. This provides an additional means of investigation that can contribute to the determination of the deceased's cause of death.

Sections du résumé

BACKGROUND
In many forensic cases, the medical records of the deceased are not available at the time of the autopsy; therefore, no information about the deceased's state of health, including any infectious diseases contracted during life, is accessible. The detection of some of the principal viral infections, such as hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus type 1 (HIV-1), could contribute to determining causes of death and interesting applications could be found in medico-legal practice, such as occupational risk assessment. To date, accurate and sensitive serological and molecular assays capable of detecting these viruses have been validated on biological samples taken from living beings, while their efficiency on forensic post-mortem biological samples has yet to be thoroughly assessed. To further this aim, this study evaluated whether the nucleic acid amplification techniques (NAATs) for the detection of viral genomes that are applied in clinical settings can be used, with the same success rate, for these latter samples.
METHODS
Manual viral nucleic acid extraction processes and fully-automated amplification-based detection techniques developed in-house were evaluated on blood samples taken during the routine autopsies of 21 cadavers performed 2 to 9 days after death. Information on HBV, HCV, and HIV-1 seropositive status was previously known for only four of these cadavers.
RESULTS
Using automated quantitative real-time PCR (qPCR) and qualitative PCR (end-point) analyses, it was possible to confirm the presence of viral genomes in the four post-mortem whole blood samples with previously reported specific serological positivity. In addition, the genomes of HCV and/or HIV-1 genomes were detected in three other blood samples with unknown serological status at the time of autopsy.
CONCLUSIONS
Therefore, our findings suggest that molecular assays may detect the presence of viral genomes in forensic post-mortem blood samples up to five days after death. This provides an additional means of investigation that can contribute to the determination of the deceased's cause of death.

Identifiants

pubmed: 35748259
pii: S2768-6701(22)00544-5
doi: 10.31083/j.fbl2706183
doi:

Substances chimiques

Nucleic Acids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

183

Informations de copyright

© 2022 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Stefania Turrina (S)

Department of Diagnostics and Public Health, Legal Medicine Section, University of Verona, 37134 Verona, Italy.

Davide Gibellini (D)

Department of Diagnostics and Public Health, Microbiology Section, University of Verona, 37134 Verona, Italy.

Giacomo Giannini (G)

Department of Diagnostics and Public Health, Legal Medicine Section, University of Verona, 37134 Verona, Italy.

Anna Lagni (A)

Department of Diagnostics and Public Health, Microbiology Section, University of Verona, 37134 Verona, Italy.

Erica Diani (E)

Department of Diagnostics and Public Health, Microbiology Section, University of Verona, 37134 Verona, Italy.

Virginia Lotti (V)

Department of Diagnostics and Public Health, Microbiology Section, University of Verona, 37134 Verona, Italy.

Giulia Soldati (G)

Department of Diagnostics and Public Health, Legal Medicine Section, University of Verona, 37134 Verona, Italy.

Filippo Gibelli (F)

Department of Diagnostics and Public Health, Legal Medicine Section, University of Verona, 37134 Verona, Italy.

Dario Raniero (D)

Department of Diagnostics and Public Health, Legal Medicine Section, University of Verona, 37134 Verona, Italy.

Domenico De Leo (D)

Department of Diagnostics and Public Health, Legal Medicine Section, University of Verona, 37134 Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH